Abstract Details
|
Pouya Khankhanian, MD
(Kaiser Dublin)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Jay Pathmanathan, MD, PhD (Penn Neuroscience Center) | No disclosure on file |
| Colin A. Ellis, MD (University of Pennsylvania) | Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. |
| Ingo Helbig, MD (Children's Hospital of Philadelphia) | The institution of Dr. Helbig has received research support from NIH, German Research Foundation, The Hartwell Foundation, International League Against Epilepsy. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care. |
| Brian Litt, MD (Univ of Penn Dept of Neurology) | Dr. Litt has received personal compensation in the range of $0-$499 for serving as a Consultant for Beacon Neurosystems. Dr. Litt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG. Dr. Litt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Litt has stock in Orph AI. Dr. Litt has stock in Hyperfine. Dr. Litt has stock in Detect. Dr. Litt has stock in Butterfly. Dr. Litt has stock in Identifeye. Dr. Litt has stock in Protein Evolution. The institution of Dr. Litt has received research support from Mirowski Foundation. The institution of Dr. Litt has received research support from Jonathan and Bonnie Rothberg. The institution of Dr. Litt has received research support from Neil and Barbara Smit. Dr. Litt has received intellectual property interests from a discovery or technology relating to health care. |
| John R. Pollard, MD (Christiana Care Neurology) | No disclosure on file |
| Kathryn A. Davis, MD (University of Pennsylvania) | Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care. |